PRAX vs EXEL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 23, 2026

PRAX

38.3
AI Score
VS
EXEL Wins

EXEL

52.2
AI Score

Investment Advisor Scores

PRAX

38score
Recommendation
SELL

EXEL

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PRAX EXEL Winner
Net Income -214.36M 422.52M EXEL
Operating Income -229.15M 499.75M EXEL
ROE -62.4% 22.9% EXEL
ROA -54.1% 16.9% EXEL
Total Assets 396.39M 2.49B EXEL
Cash 149.53M 281.45M EXEL
Current Ratio 5.18 3.46 PRAX
Free Cash Flow -172.80M 551.26M EXEL

Relative Price Performance (Last 90 Days)

PRAX 1M: +16.6% · 3M: +7.2% EXEL 1M: -2.8% · 3M: +8.9%

Current Technical Phase

PRAX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.3% over 20 days), RSI 59

RSI (14): 59.4 · Price: $375.94

EXEL

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.4 · Price: $54.08

Fundamentals Snapshot

Metric PRAX EXEL
Market Cap
Forward P/E -38.7 13.0
Trailing P/E 16.9
Revenue (TTM)
Revenue Growth 13.5% 0.1%
Gross Margin -39.0% 1.0%
Operating Margin 0.0% 0.4%
EPS -13.52 3.18
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, EXEL is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.